The 21-gene Oncotype DX Recurrence Score assay is a validated assay to help decide the appropriate treatment for estrogen receptor-positive (ER+), early-stage breast cancer (EBC) in the adjuvant setting.

READ FULL ARTICLE Curated publisher From theoncologist.alphamedpress.org